Kinin B1 receptor regulates interactions between neutrophils and endothelial cells by modulating the levels of Mac-1, LFA-1 and intercellular adhesion molecule-1

Innate Immunity

Volumn 21, Issue 3, 2015, Pages 289-304

  Figueroa, Carlos D ^a   Matus, Carola E ^a   Pavicic, Francisca ^a   Sarmiento, Jose ^a   Hidalgo, Maria A ^a   Burgos, Rafael A ^a   Gonzalez, Carlos B ^a   Bhoola, Kanti D ^a   Ehrenfeld, Pamela ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

Author keywords

bradykinin; CD11a CD18; CD11b CD18; diapedesis; inflammation; Kinin B1 receptor

Indexed keywords

BRADYKININ B1 RECEPTOR; CD11B ANTIGEN; CELL ADHESION MOLECULE; CYCLOHEXIMIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; PLATELET ENDOTHELIAL ADHESION MOLECULE 1; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; KALLIDIN; KALLIDIN, DES-ARG(10)-;

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEUTROPHIL; AGONISTS; ANALOGS AND DERIVATIVES; CELL COMMUNICATION; CELL CULTURE; CELL MOTION; DRUG EFFECTS; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM;

CELL ADHESION; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; CYCLOHEXIMIDE; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; KALLIDIN; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; NEUTROPHILS; RECEPTOR, BRADYKININ B1; RNA, SMALL INTERFERING;

EID: 84924806680     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425914529169     Document Type: Article

References (54)

1. Vaughn DE, Bjorkman PJ. The (Greek) key to structures of neural adhesion molecules. Neuron. 1996; 16: 261-273
2. Aplin AE, Howe A, Alahari SK, Juliano RL. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev. 1998; 50: 197-263
3. Dustin ML, Rothlein R, Bhan AK, et al. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol. 1986; 137: 245-254
4. Marelli-Berg FM, Nourshargh S Leukocyte trafficking molecular mechanisms, therapeutic targets and methods. Hamann A Engelhardt B, ed. Darmstadt: Wiley-VCH; 2005: 82-108.
5. Hatfield CA, Brashler JR, Winterrowd GE, et al. Intercellular adhesion molecule-1-deficient mice have Ab responses but impaired leukocyte recruitment. Am J Physiol. 1997; 273: L513 - L523
6. Bhoola KD, Figueroa CD, Whorthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992; 44: 1-80
7. Leeb-Lundberg LM, Marceau F, Müller-Esterl W, et al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005; 57: 27-77
8. Gustafson EJ, Schmaier AH, Wachtfogel YT, et al. Human neutrophils contain and bind high molecular weight kininogen. J Clin Invest. 1989; 84: 28-35
9. Figueroa CD, Henderson LM, Kaufmann J, et al. Immunovisualization of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils. Blood. 1992; 79: 754-759
10. Henderson LM, Figueroa CD, Müller-Esterl W, Bhoola KD. Assembly of contact phase factors on the surface of the human neutrophil membrane. Blood. 1994; 84: 474-482
11. Figueroa CD, MacIver AG, Bhoola KD. Identification of a tissue kallikrein in human polymorphonuclear leucocytes. Br J Haematol. 1989; 72: 321-328
12. Ehrenfeld P, Millan C, Matus CE, et al. Activation of kinin B1 receptors induces chemotaxis of human neutrophils. J Leukoc Biol. 2006; 80: 117-124
13. Stuardo M, Gonzalez CB, Nualart F, et al. Stimulated human neutrophils form biologically active kinin peptides from high and low molecular weight kininogens. J Leukoc Biol. 2004; 75: 631-640
14. Kuhr F, Lowry J, Zhang Y, et al. Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides. 2010; 44: 145-154
15. Regoli D, Barabe J. Pharmacology of bradykinin and related kinin. Pharmacol Rev. 1980; 32: 1-46
16. Linz W, Wiemer G, Gohlke P, et al. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995; 47: 25-49
17. Figueroa CD, Marchant A, Novoa U, et al. Differential distribution of bradykinin B2 receptors in the rat and human cardiovascular system. Hypertension. 2001; 37: 110-120
18. Vianna RMJ, Calixto JB. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy. Br J Pharmacol. 1998; 123: 281-291
19. Araujo RC, Kettritz R, Fichtner I, et al. Altered neutrophil homeostasis in kinin B1 receptor-deficient mice. Biol Chem. 2001; 382: 91-95
20. Ehrenfeld P, Matus CE, Pavicic F, et al. Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease-9 and myeloperoxidase in human neutrophils: involvement of mitogen-activated protein kinase family. J Leukoc Biol. 2009; 86: 1179-1189
21. Guevara-Lora I, Labedz A, Skrzeczynska-Moncznik J, Kozik A. Bradykinin and des-Arg10-kallidin enhance the adhesion of polymorphonuclear leukocytes to extracellular matrix proteins and endothelial cells. Cell Commun Adhes. 2011; 18: 67-71
22. Shigematsu S, Ishida S, Gute DC, Korthuis RJ. Bradykinin-induced proinflammatory signaling mechanisms. Am J Physiol Heart Circ Physiol. 2002; 283: H2676 - H2686
23. Sainz IM, Uknis AB, Isordia-Sala I, et al. Interactions between bradykinin (BK) and cell adhesion molecule (CAM) expression in peptidoglycan-polysaccharide (PG-PS)-induced arthritis. FASEB J. 2004; 18: 887-889
24. Imaizumi T, Yagihashi N, Hatakeyama M, et al. Upregulation of retinoic acid-inducible gene-I in T24 urinary bladder carcinoma cells stimulated with interferon-gamma. Tohoku J Exp Med. 2004; 203: 313-318
25. Menden H, Tate E, Hogg N, Sampath V. LPS-mediated endothelial activation in pulmonary endothelial cells: role of Nox2-dependent IKK-β phosphorylation. Am J Physiol Lung Cell Mol Physiol. 2013; 304: L445 - L455
26. Heikinheimo K, Voutilainen R, Happonen RP, Miettinen PJ. EGF receptor and its ligands, EGF and TGF-alpha, in developing and neoplastic human odontogenic tissues. Int J Dev Biol. 1993; 37: 387-396
27. Ehrenfeld P, Conejeros I, Pavicic MF, et al. Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and insensitive breast cancer cells. Cancer Lett. 2011; 301: 106-118
28. Hess JF, Derrick AW, MacNeil T, Borkowski JA. The agonist selectivity of a mouse B1 bradykinin receptor differs from human and rabbit B1 receptors. Int Immunopharmacol. 1996; 33: 1-8
29. Mazenot C, Loufrani L, Henrion D, et al. Endothelial kinin B1-receptors are induced by myocardial ischaemia-reperfusion in the rabbit. J Physiol. 2001; 530 (Pt 1). 69-78
30. Molina L, Matus CE, Astroza A, et al. Stimulation of the bradykinin B1 receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway. Breast Cancer Res Treat. 2009; 118: 499-510
31. Steeber DA, Tang ML, Green NE, et al. Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. J Immunol. 1999; 163: 2176-2186
32. Paegelow I, Trzeczak S, Böckmann S, Vietinghoff G. Migratory responses of polymorphonuclear leukocytes to kinin peptides. Pharmacology. 2002; 66: 153-161
33. Göbel K, Pankratz S, Schneider-Hohendorf T, et al. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. J Autoimmun. 2011; 36: 106-114
34. Zarbock A, Ley K, McEver RP, Hidalgo A. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood. 2011; 118: 6743-6751
35. Hu N, Westra J, Rutgers A, et al. Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoAb-associated vasculitides potentially increases neutrophil adhesion and impairs migration. Arthritis Res Ther. 2011; 13: R201 - R201
36. Shima C, Majima M, Katori M. A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma. Japan J Pharmacol. 1992; 60: 111-119
37. Zhou X, Gao XP, Fan J, et al. LPS activation of Toll-like receptor 4 signals CD11b/CD18 expression in neutrophils. Am J Physiol Lung Cell Mol Physiol. 2005; 288: L655 - L662
38. Hogg N. Roll, roll, roll your leucocyte gently down the vein. Immunol Today. 1992; 13: 113-115
39. Pober JS, Gimbrone MA, Collins T, et al. Interactions of T lymphocytes with human vascular endothelial cells: role of endothelial cells surface antigens. Immunobiology. 1984; 168: 483-494
40. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994; 8: 504-512
41. Nakagawa N, Sano H, Iwamoto I. Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration. Peptides. 1995; 16: 721-725
42. Roebuck KA, Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol. 1999; 66: 876-888
43. Liu G, Place AT, Chen Z, et al. ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration. Blood. 2012; 120: 1942-1952
44. Yan W, Zhao K, Jiang Y, et al. Role of p38 MAPK in ICAM-1 expression of vascular endothelial cells induced by LPS. Shock. 2002; 17: 433-438
45. Krunkosky TM, Fischer BM, Martin LD, et al. Effects of TNF-alpha on expression of ICAM-1 in human airway epithelial cells in vitro. Signaling pathways controlling surface and gene expression. Am J Respir Cell Mol Biol. 2000; 22: 685-692
46. van Buul JD, van Rijssel J, van Alphen FP, et al. ICAM-1 clustering on endothelial cells recruits VCAM-1. J Biomed Biotechnol. 2010; 2010: 120328-120328
47. van Buul JD, van Rijssel J, van Alphen FP, et al. Inside-out regulation of ICAM-1 dynamics in TNF-alpha-activated endothelium. PLoS One. 2010; 5: e11336 - e11336
48. Choi H, Fleming NW, Serikov VB. Contact activation via ICAM-1 induces changes in airway epithelial permeability in vitro. Immunol Invest. 2007; 36: 59-72
49. Wedmore CV, Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1980; 289: 646-650
50. Arfors KE, Lundberg C, Lindbom L, et al. A monoclonal Ab to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood. 1987; 69: 338-340
51. Gautam N, Herwald H, Hedqvist P, Lindbom L. Signaling via β2 integrins triggers neutrophil-dependent alteration in endothelial barrier function. J Exp Med. 2000; 191: 1829-1839
52. Gautam N, Olofsson AM, Herwald H, et al. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat Med. 2001; 7: 1123-1127
53. Berritini M, Schleef RR, Heeb MJ, et al. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells. J Biol Chem. 1992; 267: 19833-19839
54. Majno E, Shea SM, Seventhal M. Endothelial contraction induced by histamine type mediators: an electron microscopy study. J Cell Biol. 1969; 42: 647-672